This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Perinatal HIV Research Unit | |
|---|---|
| Name | Perinatal HIV Research Unit |
| Established | 1991 |
| Location | Soweto, Johannesburg, Gauteng, South Africa |
| Type | Medical research institute |
| Fields | HIV/AIDS, Perinatology, Paediatrics, Epidemiology |
| Affiliations | University of the Witwatersrand, National Institutes of Health, World Health Organization |
Perinatal HIV Research Unit The Perinatal HIV Research Unit is a clinical and research center based in Soweto, Johannesburg, Gauteng, South Africa dedicated to prevention of mother-to-child transmission and treatment of HIV/AIDS in neonates and pregnant people. It operates at the intersection of clinical trials, public health implementation and paediatric care, collaborating with institutions such as the University of the Witwatersrand, National Institutes of Health, World Health Organization, Centers for Disease Control and Prevention and regional health departments. The Unit has contributed to landmark studies influencing guidelines from bodies like the South African Department of Health, UNAIDS and the Global Fund to Fight AIDS, Tuberculosis and Malaria.
The Unit functions as a translational research site linking clinical services, epidemiological surveillance and health systems research to global policy, engaging with organizations including MSF, Bill & Melinda Gates Foundation, Clinton Health Access Initiative and academic partners such as University College London and Harvard Medical School. Its remit covers clinical trials, cohort studies, laboratory diagnostics, pharmacology and implementation science, interfacing with regulatory authorities such as the South African Health Products Regulatory Authority and international ethics bodies like the Helsinki Declaration review frameworks. The Unit’s patient population and research outputs have informed treatment algorithms endorsed by World Health Organization guidelines, Eastern Cape Department of Health programs and regional networks including the African Society for Laboratory Medicine.
Founded in the early 1990s amid the HIV/AIDS pandemic, the Unit emerged as part of responses led by institutions including the University of the Witwatersrand, Chris Hani Baragwanath Hospital and initiatives supported by the US President's Emergency Plan for AIDS Relief and National Institutes of Health. Key milestones include participation in trials that influenced recommendations by UNAIDS, the World Health Organization and the South African National Department of Health for antiretroviral prophylaxis, maternal treatment strategies promoted by Paediatric AIDS Clinical Trials Group partners and demonstration projects aligned with Global Fund investments. Over time the Unit expanded laboratory capacity with support from entities such as Wellcome Trust and the Bill & Melinda Gates Foundation and integrated into regional research networks involving University of Cape Town and Stellenbosch University.
Research themes encompass prevention of mother-to-child transmission, antenatal viral suppression, paediatric antiretroviral therapy, neonatal pharmacokinetics and long-term outcomes of exposed infants, often in consortia with National Institutes of Health, European & Developing Countries Clinical Trials Partnership, Fogarty International Center and academic centers like Oxford University and Columbia University. Studies address implementation science, health systems strengthening and community-based interventions linked to programs by UNAIDS, World Health Organization and regional ministries such as the Gauteng Department of Health. The Unit contributes to clinical trial networks including the HIV Prevention Trials Network and collaborates with pharmaceutical partners like GlaxoSmithKline and Gilead Sciences for paediatric formulations, incorporating laboratory methods from National Health Laboratory Service platforms.
The Unit provides integrated antenatal, obstetric and paediatric services in partnership with Chris Hani Baragwanath Hospital and municipal clinics, offering antiretroviral therapy compliant with South African National Department of Health protocols and WHO consolidated guidelines. Clinical care includes HIV testing, viral load monitoring using platforms endorsed by World Health Organization and point-of-care diagnostics supported by collaborations with FIND and the Bill & Melinda Gates Foundation. Multidisciplinary teams draw from paediatricians trained at University of the Witwatersrand Medical School, obstetricians who have participated in International Federation of Gynecology and Obstetrics programs and counsellors trained in models promoted by UNAIDS and UNICEF.
The Unit runs training programs for clinicians, nurses and laboratory staff in conjunction with institutions such as University of the Witwatersrand, South African Medical Research Council, University of Pretoria and international partners like Johns Hopkins University and Imperial College London. Community outreach engages local organizations including Soweto Community Health groups, Civil Society Forum affiliates and advocacy networks connected to Treatment Action Campaign initiatives, focusing on prevention, treatment literacy and stigma reduction aligned with UNAIDS targets. Capacity-building includes mentorship, postgraduate fellowships and research training supported by funders such as the Wellcome Trust and the Fogarty International Center.
The Unit maintains formal and informal links with universities like University of Cape Town, Stellenbosch University and University of the Witwatersrand; international funders and research agencies such as National Institutes of Health, European & Developing Countries Clinical Trials Partnership and Bill & Melinda Gates Foundation; public bodies including the South African National Department of Health and Gauteng Department of Health; and implementation partners like Clinton Health Access Initiative and MSF. Collaborative clinical trials and cohort studies have involved networks including the HIV Prevention Trials Network, Paediatric HIV/AIDS Cohort Study and regional consortia coordinated with African Academy of Sciences initiatives.
Governance structures align with academic oversight by the University of the Witwatersrand and institutional review boards modeled on Declaration of Helsinki principles, with ethical review involving local ethics committees and collaborations with South African Health Products Regulatory Authority where applicable. Funding streams combine government allocations via the South African National Department of Health, international grants from National Institutes of Health, philanthropic support from Wellcome Trust and Bill & Melinda Gates Foundation and competitive awards from entities such as the Global Fund to Fight AIDS, Tuberculosis and Malaria. Ethical priorities include informed consent standards promoted by World Health Organization, protection of vulnerable populations per UNICEF frameworks and data-sharing agreements consistent with policies from International Committee of Medical Journal Editors and funder mandates.
Category:Medical research institutes Category:HIV/AIDS research organizations